000 | 02685cam a22004574a 4500 | ||
---|---|---|---|
005 | 20150712005538.0 | ||
008 | 021104s2002 enka b 001 0 eng | ||
010 | _a 2005472326 | ||
015 | _aGBA2-74425 | ||
016 | 7 |
_a101159825 _2DNLM |
|
020 | _a0854046313 | ||
035 | _a(OCoLC)ocm50939443 | ||
040 |
_aNLM _cNLM _dUKM _dIXA _dWCM _dDLC |
||
042 | _apcc | ||
050 | 0 | 0 |
_aRS403 _b.M395 2002 |
060 | 0 | 0 | _a2002 M-975 |
060 | 1 | 0 |
_aQV 744 _bM4894 2002 |
082 | 0 | 4 |
_a615.19 _221 |
084 |
_a615.19 _bK M |
||
100 | 1 | _aKing, Frank D. | |
245 | 1 | 0 |
_aMedicinal chemistry _h[[Book] :] _bprinciples and practice / _cedited by Frank D. King. |
250 | _a2nd ed. | ||
260 |
_aCambridge, UK : _bRoyal Society of Chemistry, _cc2002. |
||
300 |
_axxvi, 448 p. : _bill. ; _c24 cm. |
||
504 | _aIncludes bibliographical references and index. | ||
505 | 0 | _aDrug-receptor interactions / Rob Leurs -- An introduction to ion channels / Brian Cox -- Intercellular targets / Eric Hunt ... [et al.] -- Enzyme inhibitors / David A. Roberts and Walter H.J. Ward -- Biological evaluation of novel compounds / Gary W. Price, Graham J. Riley and Derek N. Middlemiss -- Pharmacokinetics / Phillip Jeffrey -- Drug metabolism / Stephen E. Clarke -- Toxicology in the drug discovery process / Susan M. Evans, Elisabeth George and C. Westmoreland -- Chemical development / Paul Smith -- Physicochemical properties / Han van de Waterbeemd -- Quantitative structure. | |
505 | 0 | _a: activity relationships / David J. Livingstone -- Computational chemistry and target structure / Colin Edge -- Patent medicine / Bill Tyrrell -- An introduction to molecular biology / Ralph Rapley and Robert J. Slater -- Strategy and tactics in drug discovery / Frank D. King -- Combinatorial chemistry : tools for the medicinal chemist / Morag A.M. Easson and David C. Rees -- The identification of selective 5-HT2c receptor antagonists : a new approach to the treatment of depression and anxiety / Steven M. Bromidge -- The identification of the HIV protease inhibitor. | |
505 | 0 | _asaquinavir / Frank D. King -- Discovery of vioxx (rofecoxib) / Frank D. King -- NK1 receptor antagonists / Chris Swain. | |
521 | _aAll Ages. | ||
650 | 0 | _aPharmaceutical chemistry. | |
650 | 1 | 2 | _aChemistry, Pharmaceutical. |
700 | 1 | _aKing, Frank D. | |
710 | 2 | _aRoyal Society of Chemistry (Great Britain) | |
906 |
_a7 _bcbc _cpccadap _d2 _encip _f20 _gy-gencatlg |
||
923 | _acopyright | ||
925 | 0 |
_aacquire _b2 shelf copies _xpolicy default |
|
955 |
_anb05 2005-10-14 to ASCD for processing _ajx00 2005-12-14 _ijx03 2006-01-19 _ejx03 2006-01-19 to Dewey |
||
001 | 0000025742 | ||
003 | 0000 | ||
942 | _cBK | ||
999 |
_c55437 _d55437 |